Health Alert:

Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Covid Calls

Vaccine Scheduling Update: We’re experiencing very high call volumes from people interested in getting the COVID-19 vaccine. Currently, our vaccine supply is very small, and we are unable to accept phone calls to schedule vaccine appointments. Please check back here for updates.

Pharmacogenomics Research Projects

Please contact Sony Tuteja, PharmD, MS if you are interested in collaborating on pharmacogenomics research projects at sonyt@pennmedicine.upenn.edu.

Impact of Pharmacogenetic Variants in the University of Pennsylvania Health System

The goal of this project is to identify actionable pharmacogenetics variants within the Penn Biobank and develop methods to identify drug-related outcomes in the electronic health record. Principal Investigators: Sony Tuteja, PharmD, MS

Learn more about Dr. Sony Tuteja’s Precision Medicine Accelerator Fund Project.

Clinical Implementation of CYP2C19 testing

The goals of this project are to establish CYP2C19 as a clinical test, initiate and create clinical decision support tools within the electronic health record, create a workflow for pharmacogenetic test billing and assess economic impact, and assess the need for provider and patient education. CYP2C19-Clopidogrel testing information. Investigators: Sony Tuteja, PharmD, MS and Jay Giri, MD, MPH

Assessment of prospective CYP2C19 genotype guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention (the ADAPT Study)

The purpose of this study is to determine the clinical impact of CYP2C19 genotyping following percutaneous coronary intervention (PCI). Clinical trials.gov registration: NCT02508116 – Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention (ADAPT). Investigators: Sony Tuteja, PharmD, MS and Jay Giri, MD, MPH

Share This Page: